insights_auto
Outlook: 20.0% bullish·30.0% bearish
Go to analysischevron_right
M1RN34:BVMF
Moderna Inc Bdr
56,00 R$
0,00%
(0,00) 1D
9 հոկ, 17:06:00 GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for M1RN34...
Open
49,70 R$
High
56,00 R$
Low
49,30 R$
Mkt. cap
89,83 մլրդ
Avg. vol.
105,76 հզր
Volume
237,49 հզր
52-wk high
56,00 R$
52-wk low
6,02 R$
Shares outstanding
399,24 մլն
No. of employees
5 հզր
Open
49,70 R$
High
56,00 R$
Low
49,30 R$
Mkt. cap
89,83 մլրդ
Avg. vol.
105,76 հզր
Volume
237,49 հզր
52-wk high
56,00 R$
52-wk low
6,02 R$
Shares outstanding
399,24 մլն
No. of employees
5 հզր
News stories
From web sources and news partners
MarketBeat
·
10 ժամ առաջ
11,652 Shares of Moderna, Inc. $MRNA Acquired by Gallagher Capital Advisors LLC
The Globe and Mail
·
22 ժամ առաջ
This Stock Is Up More than 560% This Year, but It Could Drop by 38%, According to Wall Street
Yahoo Finance
·
22 ժամ առաջ
Moderna stock hits 4-year high on planned national cancer vaccine effort
Profile
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".
The company's commercial products are the Moderna COVID-19 vaccine sold under the brand names Spikevax and Mnexspike, a respiratory syncytial virus vaccine sold under the brand name Mresvia, and an influenza vaccine sold under the brand name Mflusiva. The company has 44 treatment and vaccine candidates, of which 37 have entered clinical trials. Candidates include possible vaccines for influenza, HIV, Epstein–Barr virus, the Nipah virus, chikungunya, human metapneumovirus, varicella zoster virus, as well as a cytomegalovirus vaccine, a Zika virus vaccine funded by the Biomedical Advanced Research and Development Authority, and three cancer vaccines.
In May 2026, Time ranked Moderna first in their list of the World's Most Impactful Companies. Wikipedia
About Moderna Inc Bdr